يعرض 1 - 10 نتائج من 32 نتيجة بحث عن '"controlled clinical trial"', وقت الاستعلام: 1.07s تنقيح النتائج
  1. 1

    المساهمون: TNO Kwaliteit van Leven

    المصدر: American Journal of Clinical Nutrition, 4, 91, 1044-1059

  2. 2

    المساهمون: Universidade Estadual Paulista (Unesp), Universidade de São Paulo (USP)

    المصدر: Brazilian Oral Research, Vol 22, Iss 1, Pp 67-71 (2008)
    Scopus
    Repositório Institucional da UNESP
    Universidade Estadual Paulista (UNESP)
    instacron:UNESP
    Brazilian Oral Research v.22 n.1 2008
    Brazilian Oral Research
    Sociedade Brasileira de Pesquisa Odontológica (SBPqO)
    instacron:SBPQO
    Brazilian Oral Research, Volume: 22, Issue: 1, Pages: 67-71, Published: MAR 2008

    وصف الملف: text/html

  3. 3

    المصدر: International Journal of Sports Medicine. 29:110-115

  4. 4

    المساهمون: Pharmaceutical Technology and Biopharmacy, Biopharmaceuticals, Discovery, Design and Delivery (BDDD)

    المصدر: Journal of Cystic Fibrosis, 3(1), 23-28. ELSEVIER SCIENCE BV

    مصطلحات موضوعية: double blind procedure, colistin parenteral, Pilot Projects, Severity of Illness Index, Cystic fibrosis, Pulmonary function testing, cystic fibrosis, polycyclic compounds, Medicine, Outpatient clinic, dry powder, outpatient care, heat sensation, clinical article, Cross-Over Studies, Inhalation, beta 2 adrenergic receptor stimulating agent, nebulization, colistimethate, adult, throat disease, drug effect, pilot study, article, clinical trial, forced expiratory volume, Respiratory Function Tests, Treatment Outcome, female, sweating, Tolerability, Anesthesia, bronchospasm, Pseudomonas aeruginosa, Dry powder inhalation, disease severity, lipids (amino acids, peptides, and proteins), medicine.drug, Pulmonary and Respiratory Medicine, crossover procedure, lung function test, mucus secretion, side effect, Bronchoconstriction, Risk Assessment, Drug Administration Schedule, Double-Blind Method, male, Administration, Inhalation, Humans, controlled study, Pediatrics, Perinatology, and Child Health, human, coughing, Probability, Dose-Response Relationship, Drug, controlled clinical trial, thorax disease, Adverse effects, Colistin, business.industry, Nebulizers and Vaporizers, Inhaler, lung function, drug preference, biochemical phenomena, metabolism, and nutrition, bacterial infections and mycoses, medicine.disease, drug efficacy, Gram negative infection, randomized controlled trial, Pediatrics, Perinatology and Child Health, bacteria, business, drug tolerability, Follow-Up Studies, Colistimethate

    وصف الملف: application/pdf

  5. 5

    المساهمون: Nanomedicine & Drug Targeting, Pharmaceutical Technology and Biopharmacy, Biopharmaceuticals, Discovery, Design and Delivery (BDDD)

    المصدر: European Journal of Clinical Pharmacology, 56(3), 219-223. Springer Verlag

  6. 6

    المصدر: GMS Health Technology Assessment
    GMS Health Technology Assessment; VOL: 7; DOC01 /20110202/
    GMS Health Technology Assessment, Vol 7, p Doc01 (2011)

    مصطلحات موضوعية: Risikoabschätzung, validation studies as topic, Methodik, models, economic, Meta-Analyse, patients, verblindete Studie, randomisierte kontrollierte Studie, double-blind method, biomedical technology assessment, Patientensicht, Effizienz, Pflege, triple blind, specifity, humans, cost-benefit-analyses, report, Lebensqualität, patientenrelevante Endpunkte, Ökonomie, Multicenter Studie, patient-relevant endpoint, Übersichtsliteratur, HTA, review literature as topic, patienten-relevant, health policy, Rechte, patient report, lcsh:R855-855.5, Diagnose, double blind method, technology, Kostensenkung, PATIENTENZUFRIEDENHEIT, randomisierte kontrollierte Studien, SOZIALÖKONOMISCHE FAKTOREN, kontrollierte klinische Studien, medical evaluation, single-blind procedure, randomisierte Zuordnung, single-blind method, Metaanalyse, Arthritis, rheumatoide, Mammatumoren, Mensch, Article, methods, Mammakarzinom, multizentrische Studien, Zufall, placebos, Behandlung, Technikfolgen-Abschätzung, biomedizinische, patienten-relevante Endpunkte, multicenter studies as topic, prospektive Studien, HTA-report, patient statement, single blind method, HTA report, validation studies, cross-over procedure, Gesundheitsökonomie, Genauigkeitsstudie, triple-blind procedure, health economic studies, DOPPELBLINDMETHODE, randomized clinical trial, sensitivity, Patientenurteil, systematische Übersicht, patient-relevant, META-ANALYSIS AS TOPIC, TECHNOLOGIE, quality of life, randomized controlled trial, Kosten Effektivität, Gesundheitszustand, Multizenterstudie, meta analysis, evidence based medicine, patient satisfaction, Multicenter-Studie, costs, randomized controlled study, sozioökonomische Faktoren, randomised clinical trial, gesundheitsökonomische Studien, Methoden, multicenter trials, health economics, cross-over trials, cost-benefit analyses, Crossoverstudien, cost effectiveness, tripleblind method, randomised controlled study, Verblindung, Beurteilung, health, trial, Patientenbeurteilung, triple blind procedure, RANDOMISIERUNG, Sensitivität, randomised clinical study, multicenter studies, research article, arthritis, controlled clinical trials as topic, Kosten und Kostenanalyse, Kosten-Nutzen-Analyse, technology evaluation, GESUNDHEITSPOLITIK, evidence-based medicine, randomisierter Versuch, sozio-ökonomische Faktoren, CT, EBM, Forschungsartikel, Konzept, review, arthritis, rheumatoid, trial, cross-over, effectiveness, socioeconomic factors, Placeboeffekt, Prävention, costs and cost analysis, decision making, breast cancer, socioeconomics, Mensch, Entscheidungsfindung, PLAZEBOS, Evaluationsstudien, VALIDIERUNGSSTUDIEN, Sozioökonomie, care, ÖKONOMIE, ÄRZTLICHE, cost control, Multicenterstudie, therapy, controlled clinical trial, Technologie, medizinische, blinded trial, Selbsteinschätzung, economics, meta-analysis, PATIENTEN, Patientenangabe, placebo, evaluation studies as topic, research-article, random allocation, randomized study, double-blind procedure, economic, double blind procedure, diagnosis, doubleblind, medizinische Beurteilung, technology assessment, biomedical, multicenter trial, Patientenbericht, Kostenminimierung, prevention, Kostenanalyse, cost analysis, breast neoplasms, cross-over studies, Vorsorge, lcsh:R723-726, single-blind, Health Technology Assessment, risk assessment, Crossover-Studien, technical report, 610 Medical sciences, Medicine, Crossover-Verfahren, meta analysis as topic, Kosten, kontrollierte klinische Versuche, cost-cutting, KLINISCHE STUDIEN, MENSCHENRECHTE, Patientenaussage, evidenzbasierte Medizin, cost reduction, COST-BENEFIT ANALYSIS, lcsh:Medical technology, rheumatoid, Gesundheitsfinanzierung, PLAZEBOEFFEKT, Plazebo, randomization, patient-reported outcome, biomedical, single blind, verblindet, medical costs, rehabilitation, HTA Bericht, sozialökonomisch, trial, crossover, blinding, sickness costs, randomisation, crossover, clinical trials, EINFACHBLINDMETHODE, endpoint, Cross-over-Studien, blinded study, accident, technology assessment, economic aspect, Reha, ethics, randomised trial, prospective studies, CCT, HUMAN RIGHTS, rights, lcsh:Medical philosophy. Medical ethics, randomised controlled trial, randomisierte klinische Studie, carcinoma of the breast, rheumatoid arthritis, Kostenreduktion, Krankheitskosten, efficacy, kontrollierte klinische Studie, randomized controlled trials as topic, health status, Pharmaökonomie, Endpunktbestimmung, medical, systematic review, pharmacoeconomics, medizinische Bewertung, HTA-Bericht, randomized trial, clinical studies, Cross-over-Verfahren, cross-over, controlled clinical study, Modelle, ökonomische, treatment, clinical trials as topic, technology, medical, triple blind method, juridical, judgement, medizinische Technologie, Kosteneffektivität, Kosten-Effektivität, Technologiebeurteilung, social economic factors, Recht, ddc: 610, economics, medical, Endpunkt, randomisierte Studie, Crossoververfahren, Wirksamkeit, Therapie, RCT, Ethik, crossover procedure, models, Übersichtsarbeit, randomized clinical study, Spezifität, endpoint determination, cost-effectiveness, GUTACHTENBASIERTE MEDIZIN, GESUNDHEIT, single blind procedure, medical assessment, rheumatoide Arthritis, double blind, random, randomised study, review literature, klinische Studie, patient reported outcome, blinded, Multizenter-Studie, ökonomischer Aspekt, efficiency, academic review, placebo effect, Multizenter Studie, Kostenkontrolle, tripleblind, patientenrelevant, patientenberichtete Zielgröße, Effektivität, concept

  7. 7
  8. 8
  9. 9
  10. 10